SCHEMBL14725908

SCHEMBL14725908

COCCOCCNCCCCCCCCCCCCCCCCCC(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
ADRA1A P35348 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
PRMT1 Q99873 1/20 0.43
EPHX2 P34913 2/20 0.41
MAPK1 P28482 2/20 0.40
POLB P06746 2/20 0.40
TSHR P16473 3/20 0.40
LMNA P02545 2/20 0.40
NFKB1 P19838 1/20 0.40
PMP22 Q01453 1/20 0.40
KDM4E B2RXH2 3/20 0.39
TDP1 Q9NUW8 1/20 0.39
PAOX Q6QHF9 1/20 0.39
SLC22A6 Q4U2R8 1/20 0.38
SLC22A8 Q8TCC7 1/20 0.38
GPR84 Q9NQS5 1/20 0.38
PPARG P37231 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26981157 0.98 ALDH1A1 (0.53) ALDH1A1ADRA1ASMN1; SMN2MEN1KMT2A
SCHEMBL31631006 0.92 ALDH1A1 (0.55) ALDH1A1ADRA1ASMN1; SMN2MEN1KMT2A
SCHEMBL31631394 0.91 PRMT1 (0.50) ALDH1A1ADRA1AMEN1KMT2APRMT1
SCHEMBL25408551 0.90 PRMT1 (0.48) ALDH1A1ADRA1AMEN1KMT2APRMT1
SCHEMBL30771466 0.90 PRMT1 (0.48) ALDH1A1ADRA1AMEN1KMT2APRMT1
SCHEMBL30018345 0.89 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2MEN1KMT2AEPHX2
SCHEMBL20223702 0.87 TSHR (0.45) ALDH1A1SMN1; SMN2MEN1KMT2AEPHX2
SCHEMBL7365096 0.87 PAOX (0.42) ALDH1A1SMN1; SMN2MEN1KMT2AEPHX2
SCHEMBL23705000 0.87 SMN1; SMN2 (0.46) ALDH1A1SMN1; SMN2MEN1KMT2ATSHR
SCHEMBL17749225 0.87 ADRA1A (0.44) ALDH1A1ADRA1AMEN1KMT2APRMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130053315-A1 NOVEL GLP-1 DERIVATIVES NOVO NORDISK A/S 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053315-A1 NOVEL GLP-1 DERIVATIVES GLP1R, GIPR, IAPP ALDH1A1 3523/4885ADRA1A 809/4885SMN1; SMN2 3474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.